-
Sulfonylureas
Stimulate insulin secretion from beta cells by blocking K+ channel.
-
Tolazamide/Tolinase
Sulfonylureas, 1st generation, t1/2 7hrs
-
Tolbutamide/Orinase
Sulfonylureas, 1st, 4.5-6.5 hrs, no active metabolite.
-
Chlorpropamide/Diabinese
Sulfonylureas, 1st, 36 hrs, active metabolite
-
Acetohexamide/Dymelor
Sulfonylureas, 1st, 6-8hrs, active met.
-
Glipizide/Glucotrol
Sulfony., 2nd, 2-4hrs, no active met.
-
Glyburide/Diabeta
Sulfony. 2nd, nonmicronized 10hrs, weakly active met.
Micronized 4hrs.
-
Glimepiride/Amaryl
Sulfony. 3rd, 9hrs, active met. Cause translocation of the GLUT-4, and binds to a different protein then normal Sulfony.
-
Rosiglitazone/Avandia
Oral Thiazolidinediones, Type 2, works in the presence of insulin. Increase tissue sensitivity by increasing PPAR activity. Possible hepatic failure.
-
Pioglitazone/Actos
Oral Thiaz. Metabolized by 3A4, decreases oral contra.
-
Repaglinide/Prandin
Type 2, Non-Sulfonylurea analog, Stimulates insulin secretion.
-
Metformin/Glucophage
Type 2, decrease hepatic gluconeogenesis, decrease GI glucose absorption, increase peripheral insulin sensitivity.
-
Nateglinide/starlix
Type 2, stimulate insulin release
-
Acarbose/Precose
Type 2 as an adjunct to Sulfony or insulin, decrease carbo absorption by inhibiting alfa-glucosidase. Take with first bite of food!
-
Glipizide and Metformin
Metaglip
-
Rosiglitazone and Metformin
Avadamet
-
Glyburide and Metformin
Glucovance
-
Rosiglitazone and Glimepiride
Avandaryl
-
Pioglitazone and Metformin
ACTOplus
-
Repaglinide and Metformin
Prandimet
-
Insulin glulisine/Apidra
Recomb, rapid acting, Produced in Ecoli
-
Insulin Determir/Levemir
Recomb, long acting 24hr, also undergoes chemical mod with a fatty acid.
-
Insulin glargine/Lantus
Recomb, Forms microprecipitates in sub Q tissue prolonging duration 18-26hrs
-
Insulin aspart/Novolog
Recomb, rapid acting 3-5 hrs take before meal.
-
Insulin lispro/Humalog
Recomb, rapid acting 3-5 hrs, take before or immediatly after meal.
-
Exenatide/ Byetta
Synthetic, incretin or glucagon-like peptide, increases insulin synthesis and exretion.
-
Pramlintide/Symlin
synthetic analog of human anylin
-
Liraglutide/Victoza
incretin or glucagon-like peptide. Risk of thyroid c-cell tumor.
-
Sitagliptin/Januvia
DPP-IV inhibitor, Prolongs levels of natural incretins and increases insulin release
-
Saxagliptin/Onglyza
DDP-4 inhibitor, Adverse=decrease lymph count, hypoglycemia, headaches.
-
Linagliptin/Tradjenta
Not for type 1, subsstrate for P-glyco, inducer of 3A4
-
Bromocriptine/Cycloset
type 2 only, improve glycemic control, increases dopamine levels.
-
Becaplermin/Regranex
Human durived platelet growth factor, used to treat diabetic neuropathic ulcers, topical gel
-
Welchol/ Colesevelam
Bile acid sequestrant, improves glycemic control.
|
|
